Pfizer’s COVID vaccine has been approved for kids ages 5-11, found on Sunday to be ‘safe and effective’ by the drugmaker.
The vaccine, which was created by Pfizer and its German partner BioNTech, generated a “robust” immune response in young children during clinical trials, according to the company’s response to the new discovery. Pfizer now seeks to use the new data discovered to get the vaccine approved for use on ages 5-11 by the United States Food and Drug Administration, as well as other health organizations.
The Pfizer vaccine is already widely available for anyone ages 12 and up, having been approved for emergency authorization by the United States earlier this year. “Pfizer said the 2,268 children participating in the trial were given two doses of the vaccine 21 days apart and they had comparable antibody results to teens that were included in an earlier trial”, per a New York Post report.
“The side effects of the vaccine, including sore arms, fever or achiness, were generally comparable to those found in a trial of those aged 16 to 25 years. Unlike earlier vaccine trials that measured efficacy of the shot, this trial did not compare the number of COVID cases in vaccine recipients to those who had received a placebo.”
ARTICLE: ETHAN FINN
MANAGING EDITOR: CARSON CHOATE
PHOTO CREDITS: LA TIMES
Latest posts by Ethan Finn (see all)
- New York man arrested for forging COVID-19 vaccine card - October 8, 2021
- Texas board recommends posthumous pardon for George Floyd - October 8, 2021
- New York man arrested for forging COVID-19 vaccine card - October 6, 2021